3 Pathak S, Mohan C. Cellular and molecular pathogenesis of systemic lupus erythematosus: lessons from animal models[J]. Arthritis Res Ther, 2011, 13(5): 241.
[4]
4 Abdul-Sattar AB, Goda T, Negm MG. Neuropsychiatric manifestations in a consecutive cohort of systemic lupus erythematosus; a single center study[J]. Int J Rheum Dis, 2013, 16(6): 715-723.
[5]
5 Agarwal I, Kumar TS, Ranjini K, et al. Clinical features and outcome of systemic lupus erythematosus[J]. Indian Pediatr, 2009, 46(8): 711-715.
[6]
6 Mak A, Almsherqi ZA, Lai YW, et al. Intracellular tubulo reticular structures of peripheral blood mononuclear cells as an ultra-structural marker of disease activity in systemic lupus erythematosus: a pilot study[J]. Int J Rheum Dis, 2013, 16(6): 692-697.
8 Pérez Aceves E, Pérez Cristóbal M, Espinola Reyna GA, et al. Chronic respiratory disfunction due to diffuse alveolar hemorrhage in patients with systemic lupus erythematosus and primary vasculitis[J]. Reumatol Clin, 2013, 9(5): 263-268.
10 Borchers AT, Keen CL, Shoenfeld Y, et al. Surviving the butterfly and the wolf: mortality trends in systemic lupus erythematosus[J]. Autoimmun Rev, 2004, 3(6): 423-453.
[11]
11 Mok CC, Lee KW, Ho CT, et al. A prospective study of survival and prognostic indicators of systemic lupus erythematosus in a southern Chinese population[J]. Rheumatology, 2000, 39(4): 399-406.
[12]
12 Smolen JS. Therapy of systemic lupus erythematosus: a look into the future[J]. Arthritis Res, 2002, 4(Suppl 3): S25-S30.
[13]
13 Izmirly PM, Costedoat-Chalumeau N, Pisoni CN, et al. Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody-associated cardiac manifestations of neonatal lupus[J]. Circulation, 2012, 126(1): 76-82.
[14]
14 Jorge Asano NM, Wanderley De Sales Coriolano MD, Asano BJ, et al. Psychiatric comorbidities in patients with systemic lupus erythematosus: a systematic review of the last 10 years[J]. Rev Bras Reumatol, 2013, 53(5): 431-437.
[15]
15 Amaya-Amaya J, Sarmiento-Monroy JC, Caro-Moreno J, et al. Cardiovascular disease in latin american patients with systemic lupus erythematosus: a cross-sectional study and a systematic review[J]. Autoimmune Dis, 2013: 794383.